Category: Print

Innophore, a Graz-based bioinformatics company, has partnered with NVIDIA to develop artificial intelligence for the early detection of drug side effects. Together, they created a comprehensive dataset of human protein

Innophore was selected among the top five Material Informatics startups worldwide by StartUs Insights, based on an analysis of 173 companies working on data-driven simulation and discovery. The ranking highlights

This in-depth feature by Drug Discovery & Development traces Innophore’s journey from a 30-person Austrian startup to a strategic NVIDIA partner showcased at both the J.P. Morgan Healthcare Conference and

Austrian technology outlet futurezone reports on the expanding partnership between NVIDIA and the Graz-based biotech company Innophore, highlighted by NVIDIA CEO Jensen Huang at CES in Las Vegas. The collaboration

Pharmaceutical Technology reports on NVIDIA’s endorsement of the Innophore partnership for modelling drug dynamics with AI. Innophore’s CavitOmiX platform uses deep learning to screen for new drug candidates, predict hidden

In this official NVIDIA Success Story, Innophore demonstrates how GPU-accelerated computing, the BioNeMo framework, and Amazon Web Services are revolutionizing drug discovery workflows. By leveraging NVIDIA GPUs and RAPIDS, Innophore

What began as a practical exercise in a structural bioinformatics course at the University of Graz led to a Nature Correspondence: we identified systematic stereochemical errors in AlphaFold 3, the

Yahoo Finance, via GlobalData, reports on NVIDIA championing the Innophore partnership to model drug dynamics with artificial intelligence. The CavitOmiX AI platform is designed to predict hidden side effects and

Austrian startup media Trending Topics reports on the collaboration between Innophore and NVIDIA, announced during Jensen Huang’s CES keynote address in January 2025. The Graz-based company, founded in 2017, uses

Austrian public broadcaster ORF Steiermark reports on how Innophore and NVIDIA have developed AI technology for the early detection of drug side effects. The collaboration produced a dataset containing 3D

Published in Nature Scientific Data, this paper presents a comprehensive dataset of predicted protein structures for 42,042 distinct human proteins, generated using NVIDIA’s BioNeMo platform combined with Innophore’s CavitomiX technology.

At the 42nd J.P. Morgan Healthcare Conference in San Francisco, NVIDIA CEO Jensen Huang highlighted the Innophore partnership as a key example of how generative AI is transforming drug discovery

Published in Nature Scientific Reports, this study demonstrates the power of Innophore’s DrugSolver CavitomiX pipeline for computational drug repurposing. By analyzing cavity-based point clouds representing the physico-chemical properties of SARS-CoV-2

Germany’s leading broadsheet newspaper Frankfurter Allgemeine Zeitung featured Innophore’s work on computational structural virology and the application of the Catalophore technology to SARS-CoV-2 variant analysis. The article highlights how a

January 2020 to March 2021 190 press clippings are listed below.     # Publication Media Titel (GE) Title (EN) 190 March 2021 Kleine Zeitung online Schneller als das Virus

  Austrian daily newspaper Kurier reported on Innophore’s computational approach to predicting SARS-CoV-2 mutations before they become dominant in the population. The article highlights how the Graz-based company uses structural

TERRA MATER, the Austrian nature and science magazine, featured an in-depth profile of Innophore’s research at the intersection of computational biology and pandemic response. The article explores how protein cavity

  Innophore made the cover of Kurier, one of Austria’s largest daily newspapers, with a feature story on how computational structural biology is being used to predict coronavirus mutations. The

  Trend.MED, a leading Austrian medical business publication, covered Innophore’s work on applying AI and structural bioinformatics to the fight against SARS-CoV-2. The article discusses how the company’s computational platform

  Austrian tabloid ÖSTERREICH reported on how Innophore’s computational platform is contributing to the national and international response to the COVID-19 pandemic. The coverage brought the company’s cutting-edge bioinformatics research

  SPIRIT magazine, the University of Graz’s research publication, profiled the computational structural biology research conducted by Innophore and its connection to the university’s Institute of Molecular Biosciences. The article

  Kronen Zeitung, Austria’s highest-circulation newspaper, featured Innophore’s work on SARS-CoV-2 structural analysis and computational drug discovery. The article brought the company’s research on viral protein dynamics and mutation prediction

  This Nature Scientific Reports publication demonstrated that Serine 477 plays a crucial role in the interaction between the SARS-CoV-2 spike protein and the human ACE2 receptor. The structural bioinformatics

  Published in Cell iScience, this multi-pronged study combined ultra-large virtual screening with structural bioinformatics to identify potential therapeutic compounds targeting SARS-CoV-2 proteins. Innophore contributed the dynamic structural viral proteome

  Trend Biotech, Austria’s premier biotechnology business publication, reported on Innophore’s technology platform and its applications in computational drug discovery. The article explores how the Catalophore approach enables the identification

  WIRED magazine featured Innophore’s innovative approach to computational drug discovery, highlighting how the company’s Catalophore technology uses 3D point-cloud representations of protein cavities to identify hidden enzymatic functions and

  StartUs Insights selected Innophore among the top five Material Informatics startups globally in their 2020 ranking. The analysis, based on a comprehensive scan of emerging companies in data-driven materials

  German scientific trade journal Laborjournal profiled Innophore’s computational platform and its applications in structural biology research. The article discusses how the company’s 3D point-cloud approach to protein cavity analysis

  Annual Report  The Austrian Research Promotion Agency (FFG) featured Innophore in its annual report, highlighting the company’s successful use of public research funding to develop innovative computational biology tools.

  Nature Biotechnology profiled Innophore as part of its coverage on the emerging computational biology pipeline for pandemic response. The article “The pandemic pipeline” highlights how companies and research groups

  The Hong Kong Economic Journal, one of Asia’s most respected financial newspapers, reported on Innophore’s computational approach to fighting the COVID-19 pandemic. The international coverage reflects the global reach

  Trend Special, a publication of Austria’s leading business magazine, dedicated a feature to Innophore’s role in the emerging landscape of AI-driven drug discovery. The article examines how the Graz-based

  Kleine Zeitung, Styria’s largest regional newspaper, reported on Innophore’s groundbreaking work in computational structural virology. The article highlights how the company’s platform is being used to analyze SARS-CoV-2 protein

  German scientific trade journal Laborjournal featured Innophore’s work on applying computational methods to the rapid analysis of emerging viral pathogens. The article discusses how the company’s structural bioinformatics platform

  Bloomberg reported on how Austrian bioinformatics company Innophore applied its computational platform to the structural analysis of SARS-CoV-2, contributing to the global effort to understand and combat the pandemic

  The Austrian Federal Ministry for Digital and Economic Affairs recognized Innophore’s contribution to digital innovation in biotechnology. The feature highlights how the company’s computational platform exemplifies the successful transfer

  Salzburger Nachrichten, one of Austria’s leading quality newspapers, reported on Innophore’s innovative approach to computational biology and its applications in drug discovery. The article brings attention to how a

Red Bulletin INNOVATOR, the innovation supplement of Red Bull’s international magazine, profiled Innophore as a standout Austrian deeptech company. The feature highlights the company’s Catalophore technology and its applications in

  Botenstoff, a publication dedicated to molecular biosciences communication, featured Innophore’s research in structural bioinformatics and computational biology. The article explores the scientific foundations of the company’s work in protein

  Innophore was featured on the cover of Botenstoff, the molecular biosciences communication magazine. The cover story highlights the company’s pioneering work in computational structural biology and its growing impact

  Kleine Zeitung published an extensive feature on Innophore and its computational approach to drug discovery and protein engineering. The article discusses how the Graz-based company uses 3D point-cloud technology

  Innophore was featured on the front page of Kleine Zeitung, Styria’s largest daily newspaper. The cover story brought widespread regional attention to the company’s innovative bioinformatics technology and its

  Chemiereport, Austria’s leading chemistry and life sciences trade publication, covered Innophore’s work on the Catalophore technology platform and its applications in industrial biotechnology. The article discusses how 3D point-cloud

  Der Standard’s JUST Business supplement featured Innophore in its coverage of innovative Austrian startups. The article profiles the company’s computational biology platform and its potential to transform drug discovery

Бизнес-портал косметики и клининговая промышленность

Die Presse, one of Austria’s most prestigious daily newspapers, reported on Innophore’s contributions to computational biology and the Catalophore technology. The article highlights the company’s role in bridging academic research

  Chemiereport featured Innophore’s Catalophore technology and its breakthrough application in identifying hidden enzyme activities by mining structural databases. The article discusses how 3D point-cloud representations of protein cavities enable

  Der Standard reported on the Catalophore technology and its implications for enzyme discovery and drug development. The article discusses how the computational method, developed at the University of Graz,

  ORF Science, the science section of Austria’s national public broadcaster, featured the Catalophore research and its publication in Nature Communications. The report highlights how Graz-based researchers developed a computational

  Kurier reported on the Catalophore breakthrough published in Nature Communications, highlighting how researchers at the University of Graz developed a novel computational approach to enzyme discovery. The article explains

Kleine Zeitung covered the Nature Communications publication on the Catalophore technology, featuring the research team at the University of Graz. The article discusses how the discovery of hidden ene-reductase activity

  L&B (Life and Business) featured the Catalophore technology and its potential applications in industrial biotechnology and pharmaceutical research. The article discusses how the innovative 3D point-cloud approach to protein

This landmark Nature Communications paper introduced the Catalophore technology — a method for mining structural databases using active site constellations represented as 3D point clouds. The study demonstrated the discovery

  Transkript, Germany’s leading biotechnology business magazine, featured early work on biocatalytic deracemization methods that laid the scientific foundation for the later development of the Catalophore technology. The article highlights